HO‐1 in lymph node metastasis predicted overall survival in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation therapy

BACKGROUND: Lymph node metastasis is one of the pivotal factors of the clinical outcomes of patients with esophageal cancer receiving neoadjuvant chemoradiation therapy (NACRT). Both the nuclear factor‐erythroid 2‐related factor 2 (Nrf2) signaling pathway and heme oxygenase‐1 (HO‐1) are frequently u...

Descripción completa

Detalles Bibliográficos
Autores principales: Akaishi, Ryujiro, Fujishima, Fumiyoshi, Ishida, Hirotaka, Tsunokake, Junichi, Yamauchi, Takuro, Gokon, Yusuke, Ueki, Shunsuke, Fukutomi, Toshiaki, Okamoto, Hiroshi, Takaya, Kai, Sato, Chiaki, Taniyama, Yusuke, Nakamura, Tomohiro, Nakaya, Naoki, Kamei, Takashi, Sasano, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955080/
https://www.ncbi.nlm.nih.gov/pubmed/34264023
http://dx.doi.org/10.1002/cnr2.1477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955080/
https://www.ncbi.nlm.nih.gov/pubmed/34264023
http://dx.doi.org/10.1002/cnr2.1477

Ejemplares similares